Actelion Pharmaceuticals Ltd

act-213105 - iloprost

 

Study ID Status Type Title
AC-063A301 Completed Results Summary A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients with Symptomatic Pulmonary Arterial Hypertension
AC-063A302 Completed Results Summary A Multicenter, Double-blind, Randomized Study comparing the Safety and Tolerability of Iloprost inhalation solution delivered by I-neb utilizing Power disc-15 and Power disc-6 in Patients with Symptomatic Pulmonary Arterial Hypertension
AC-063A402 Terminated Results Summary A Phase IIIb, multicenter, open-label study of patients with pulmonary arterial hypertension treated with iloprost (inhalation) evaluating safety and inhalation times when converting from power disc-6 (PD-6) to power disc-15 (PD-15) with the I-neb® AAD®
AC-063B201 Terminated Results Summary A Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the effects of inhaled iloprost on endurance time during cardiopulmonary exercise testing in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
C200-006 Terminated Results Summary A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of Inhaled Iloprost in Patients with Pulmonary Arterial Hypertension Receiving Oral Sildenafil
C200-008 Terminated Results Summary A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"